In the US, Onxol (paclitaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer and Wilms' Tumor.
US matches:
- Onxol
Ingredient matches for Onxol
Paclitaxel
Paclitaxel is reported as an ingredient of Onxol in the following countries:
- Czech Republic
International Drug Name Search
No comments:
Post a Comment